Related Experiment Video
Updated: Mar 18, 2026
08:17
Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
Published on: September 27, 2018
8.9K
Implantable Devices for Sustained, Intravesical Drug Delivery
Seung Ho Lee1, Young Bin Choy1,2,3
1Institute of Medical & Biological Engineering, Medical Research Center, Seoul National University, Seoul, Korea.
International Neurourology Journal
|July 6, 2016
Summary
Implantable devices offer sustained intravesical drug delivery for bladder diseases, improving patient compliance over repeated bolus instillations. This review highlights recent advancements in these promising drug-delivery systems.
Area of Science:
- Biomedical Engineering
- Drug Delivery Systems
- Urology
Background:
- Intravesical drug instillation is common for bladder diseases but requires frequent administration.
- Repeated treatments lead to poor patient compliance and reduced therapeutic efficacy.
- Sustained drug release is needed to overcome these limitations.
Purpose of the Study:
- To review current trends in intravesical drug-delivery device development.
- To introduce novel implantable devices for sustained drug delivery to the bladder.
- To assess the potential of new devices for clinical application.
Main Methods:
- Literature review of intravesical drug-delivery technologies.
- Analysis of recent research on implantable bladder drug-delivery systems.
- Identification of devices with high therapeutic potential.
Main Results:
- Significant progress in developing implantable devices for sustained intravesical drug delivery.
- Emerging technologies show promise for improved drug efficacy and patient compliance.
- Several recently developed devices demonstrate strong potential for clinical translation.
Conclusions:
- Implantable devices represent a significant advancement in treating bladder diseases.
- Sustained intravesical drug delivery via novel devices can enhance patient compliance and treatment outcomes.
- Further research and development of these devices are crucial for clinical adoption.
Related Concept Videos
01:21Intrauterine Drug Delivery Systems
101
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
101
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
88
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
88
01:22Drug Delivery: Miscellaneous Routes
951
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
951
01:26Oral Drug Delivery Systems: Continuous-Release Systems
163
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
163
01:18Transdermal Drug Delivery Systems
105
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
105
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
72
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
72